Prevalence of Dihydrofolate reductase gene mutations in Plasmodium falciparum isolate from pregnant women in Nigeria

Infectious Disease Reports

Volumn 3, Issue 2, 2011, Pages

  Ojurongbe, Olusola ^a,b   Tijani, Bukola D ^c   Fawole, Adegboyega A ^c   Adeyeba, Oluwaseyi A ^a   Kun, Juergen F ^b  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF ILORIN   (Nigeria)

Author keywords

Dhfr; Drug resistance; Malaria; Pregnancy

Indexed keywords

PYRIMETHAMINE PLUS SULFADOXINE;

ADULT; ALLELE; ANEMIA; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BLOOD GROUP TYPING; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG INTERMITTENT THERAPY; FEMALE; GENE; GENOTYPE; GESTATIONAL AGE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MICROORGANISM DETECTION; MULTIPARA; MUTATION RATE; MUTATIONAL ANALYSIS; NIGERIA; NONHUMAN; PARASITE DETECTION; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRIMIGRAVIDA; SECOND TRIMESTER PREGNANCY; SINGLE DRUG DOSE; THIRD TRIMESTER PREGNANCY;

EID: 84856324209     PISSN: None     EISSN: 20367449     Source Type: Journal    
DOI: 10.4081/idr.2011.e16     Document Type: Article

References (22)

1. Steketee RW, Wirima JJ, Campbell CC. Developing effective strategies for malaria prevention programs for pregnant African women. Am J Trop Med Hyg 1996;55:95-100.
2. WHO. A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville, Republic of Congo, 2004.
3. Mubyazi G, Bloch P, Kamugisha M, et al. Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern Tanzania. Malar J 2005;4:31.
4. Falade CO, Yusuf BO, Fadero FF, et al. Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria. Malar J 2007;6:88.
5. FMOH. National guidelines and strategies for malaria prevention and control during pregnancy. A publication of the Federal Ministry of Health, Nigeria. Abuja Nigeria
6. Aziken ME, Akubuo KK, Gharoro EP. Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria. Int J Gynaecol Obstet 2011;112:30-3.
7. Oyibo WA, Agomo CO. Scaling up of intermittent preventive treatment of malaria in pregnancy using sulphadoxine-pyrimethamine: prospects and challenges. Matern Child Health J 2011;15:542-52.
8. Gregson A, Plowe CV. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev 2005;57:117-45.
9. Nzila AM, Mberu EK, Sulo J, Dayo H, et al. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob Agents Chemother 2000;44:991-6.
10. Biswas S, Escalante A, Chaiyaroj S, et al. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study. Trop Med Int Health 2000;5:737-43.
11. Plowe CV, Cortese JF, Djimde A, et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 1997;176: 1590-6.
12. Alker AP, Mwapasa V, Purfield A, et al. Mutations associated with sulfadoxinepyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi. Antimicrob Agents Chemother 2005;49:3919-21.
13. Kiara SM, Okombo J, Masseno V, et al. In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation. Antimicrob Agents Chemother 2009;53:3793-8.
14. Barduagni P, Ahmed AS, Curtale F, et al. Performance of Sahli and colour scale methods in diagnosing anaemia among school children in low prevalence areas. Trop Med Int Health 2003;8:615-8.
15. Alusala DN, Estambale BB, Magnussen P, et al. Predictors of serum ferritin and haemoglobin during pregnancy, in a malaria-endemic area of western Kenya. Ann Trop Med Parasitol 2008;102:297-308.
16. Wild BJ, Bain BJ. Detection and quantitation of normal and variant haemoglobins: an analytical review. Ann Clin Biochem 2004;41:355-69.
17. Oyedeji SI, Awobode HO, Monday GC, et al. Comparison of PCR-based detection of Plasmodium falciparum infections based on single and multicopy genes. Malar J 2007;6:112.
18. Ojurongbe O, Oyedeji SI, Oyibo WA, et al. Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria. Wien Klin Wochenschr 2010;122:681-5.
19. Fawole AO, Onyeaso NC. Perception and practice of malaria prophylaxis in pregnancy among primary health care providers in Ibadan, Nigeria. West Afr J Med 2008;27:92-6.
20. Yusuf OB, Dada-Adegbola HO, Ajayi IO, Falade CO. Malaria prevention practices among mothers delivering in an urban hospital in southwest Nigeria. J Vector Borne Dis 2008;45:217-24.
21. Agomo CO, Oyibo WA, Anorlu RI, Agomo PU. Prevalence of malaria in pregnant women in Lagos, South-West Nigeria. Korean J Parasitol 2009;47:179-83.
22. Adefioye OA, Adeyeba OA, Hassan WO, Oyeniran OA. Prevalence of malaria parasite infection among pregnant women in Osogbo, southwest, Nigeria. American-Eurasian J Sci Res 2007;2:43-5.